AI Drives Nearly Half of 2025 Healthcare Investment, First Citizens BancShares Reports

Reuters
01/08
AI Drives Nearly Half of 2025 Healthcare Investment, <a href="https://laohu8.com/S/FCNCB">First Citizens BancShares</a> Reports

First Citizens BancShares Inc., through its Silicon Valley Bank division, released its 17th Healthcare Investments and Exits Report, highlighting significant trends in the healthcare investment landscape for 2025. The report reveals that artificial intelligence $(AI)$ companies accounted for 46% of total healthcare investment, with more than $18 billion directed to AI in the sector. Despite this surge in AI funding, overall healthcare investment declined to $46.8 billion in 2025, a 12% decrease from the previous year. The analysis notes growth in healthtech and medical device investments, while biopharma and diagnostics/tools sectors experienced declines. Large deals over $300 million represented 40% of total healthcare AI spending, the highest on record. The report also indicates a more selective venture capital environment, with total VC deals down 7% and healthcare-focused VCs raising $7 billion in new funds, significantly below the 2021 peak. The findings suggest a more concentrated and disciplined approach to healthcare investing, with capital increasingly directed toward companies demonstrating clinical validation and revenue traction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Citizens BancShares Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF59125) on January 08, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10